Titlebook: Omics for Personalized Medicine; Debmalya Barh,Dipali Dhawan,Nirmal Kumar Ganguly Book 2013 Springer India 2013 Genotype.Nutrition.Pharmac

廣口瓶

喃喃而言

小步舞

MIRTH

Pharmacogenomics of Autoimmune Diseasesotrexate. Polymorphisms within the . promoter region have been shown to modify the clinical efficacy and toxicity of anti-TNF therapy in RA patients. SLE patients with polymorphic . gene may require a reduced dose of azathioprine to circumvent the catastrophe of fatal bone marrow suppression. Polymo

assent

Pharmacogenomics and Personalized Medicine in Parkinsonismic makeup. The personalized medication of antiparkinsonian drug therapy; the symptomatic and regional disruptions; genetic, epigenetic, and biomarkers of the disorder; and the pharmacogenomics of neuroleptic drug-induced parkinsonism provide outlets for eventual understanding and management. As a ca

背帶

Pharmacogenomics and Personalized Medicine in Alzheimer’s Diseaseitter pathways, circuits and regional brain developments, and metabolism that reinforce the growing requirements for personalized medicine. The search for individual-based medication, in addition to genomic assay and biomarker identity, seeks to establish a “reregulation” of destructive β-amyloid pa

駁船

Pharmacogenomics and Personalized Medicine in Mood Disordersadrenal axis factors, neurotrophic factors, and inflammatory factors affecting neuroimmune function. Nevertheless, procedural considerations of pharmacogenetics presume the parallel investment of policies and regulations to withstand eventual attempts at misuse thereby ensuring patient integrity.

瘋狂

Book 2013ven discusses the ethical consideration in pharmocogenomics. The second section is focusing on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even ex

滔滔不絕地講

http://image.papertrans.cn/o/image/700921.jpg

interpose